Research study · Preventive Medicine · 2026
Assessing the association between cannabis use frequency and heart disease in adults aged under 50: National Survey on Drug Use and Health, 2021-2023
Verified on PubMed Oxford CEBM Level 2B: Clinical Cohort Study
A 2026 study in Preventive Medicine tested cannabis in heart diseases. Cannabis use is significantly associated with higher odds of heart disease among US adults under 50. This study suggests that frequent and daily cannabis use is linked to higher odds of heart disease in young adults, with risks increasing as usage frequency goes up.
In plain language
Study overview
In adults under 50, frequent and daily cannabis use is independently associated with a dose-dependent increase in the odds of early-onset heart disease. Clinicians should incorporate structured cannabis use histories into routine cardiovascular risk assessments for younger patients and counsel them on potential cardiac risks.
Findings
Cannabis use is significantly associated with higher odds of heart disease among US adults under 50. A positive linear dose-response relationship was observed, with odds of heart disease increasing with greater frequency of use. Daily cannabis users had 40% higher odds of heart disease compared to non-users (aOR = 1.40; 95% CI: 1.11, 1.76).
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
Objective: Cannabis use has increased among younger adults in the United States alongside rising rates of heart disease. This study examines the association between cannabis use frequency and heart disease among adults aged 18–49. Methods: A cross-sectional analysis of 88,166 United States adults aged 18–49 was conducted using 2021–2023 National Survey on Drug Use and Health data. Cannabis use frequency was measured as days of cannabis use in the past year. A weighted logistic regression model estimated the adjusted odds ratio (aOR) for heart disease, controlling for demographics, smoking, and heavy drinking. Additionally, A dose-response analysis was performed to further assess the relationship. Results: Cannabis users had significantly higher odds of heart disease compared to non-users. Each 90-day increase in cannabis use was associated with 9 % higher odds of heart disease (aOR: 1.09; 95 % Confidence Interval: 1.03, 1.15). Daily users had 40 % higher odds of heart disease compared to non-users (aOR = 1.40; 95 % Confidence Interval: 1.11, 1.76). A clear dose-response relationship was observed. Conclusions: Cannabis use frequency is significantly associated with higher odds of heart disease among US adults under 50. Findings demonstrate a positive linear relationship and indicate cannabis use as a potential modifiable risk factor for early-onset heart disease.
The paper
Citation
Earl M, Bhandari R Assessing the association between cannabis use frequency and heart disease in adults aged under 50: National Survey on Drug Use and Health, 2021–2023. Preventive Medicine (2026). PubMed 41175987 · DOI
Limitations the authors noted
Cross-sectional design prevents establishing causal temporality. Reliance on self-reported survey data introduces potential recall and social desirability bias. Cannabis use data is restricted to the past year and measures days of use rather than exact dosage or potency.
In practice
Why this matters
This study suggests that frequent and daily cannabis use is linked to higher odds of heart disease in young adults, with risks increasing as usage frequency goes up. However, it relies on self-reported data and a single point in time, so it does not prove that cannabis causes heart disease or how long-term use might affect risk.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding Cannabis and Heart diseases?
Cannabis use is significantly associated with higher odds of heart disease among US adults under 50. A positive linear dose-response relationship was observed, with odds of heart disease increasing with greater frequency of use. Daily cannabis users had 40% higher odds of heart disease compared to non-users (aOR = 1.40; 95% CI: 1.11, 1.76).
What study limitations or clinical safeguards should patients keep in mind?
Cross-sectional design prevents establishing causal temporality. Reliance on self-reported survey data introduces potential recall and social desirability bias. Cannabis use data is restricted to the past year and measures days of use rather than exact dosage or potency.
Browse related research
Condition: Heart diseases Topic: Cannabis Topic: Marijuana smoking Topic: Marijuana use
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 26, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.
